`
`R .D elansorne A ugust31,2018
`
`Rémi Delansorne,D .V .M .,Ph.D .
`30rue G uynem er
`75006PA R IS,France
`B ornonJuly 20th,1959
`
`Current position at Hybrigenics SA:
`
`C hiefExecutive O fficersince 2005,
`B oard D irectorsince 2007,
`C hairm anofthe B oard since 2017.
`
`2004- 2005 :
`
`V ice-PresidentR esearch& D evelopm ent
`Hybrigenics SA
`
`2002- 2004 :
`
`G lobal head ofdiabetesresearch,Merck KgaA,D arm stadt
`L ocal head ofpreclinical R & D ,Merck-Santé,L yon
`
`1999- 2002 :
`1991- 1999 :
`1987- 1991 :
`1985- 1987 :
`
`H ead ofpreclinical R & D ,Theramex,M onaco
`D eputy head ofpreclinical R & D ,Theramex,M onaco
`D irectorofpharm acology and toxicology,Theramex,M onaco
`D eputy directorofpharm acology and toxicology,Theramex,M onaco
`
`1984- 1985 :
`
`R esearchengineer- Rhône-Poulenc-Santé,Paris
`
`1982- 1983 :
`
`Post-doctoral fellow,University of Texas Medical School inH ouston
`
`D iplom as:
`
`1987
`1981
`
`:
`:
`
`Ph.D .Thesisfrom Université P. et M. Curie,Paris,inlife sciences
`D .V .M .from Alfort National Veterinary School,France
`
`Patentsand publications
`
`Inventororco-inventorof 12patentfam ilies covering antihistam ines,L H -R H analogues and oral
`form ulations of them ,pregnane- and pregnene-derived progestins,arom atase inhibitors,pan-
`ubiquitin-specific proteases (U SP)and U SP8inhibitors,and form ulations and therapeutic uses of
`inecalcitol,a vitam inD analogue.
`
`C o-authorof28PubM ed-indexed publications;h-index= 18;> 1100citations.
`
`214L T :20700:448355:1:A L EX A N D R IA
`
`EXHIBIT 1
`
`Post-Grant Review Petition for US 9,840,491
`EXHIBIT 1013
`Page 1
`
`



